Research, Select, & Monitor Saturday, July 21, 2018 5:23:47 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

Ticker Lookup
Flotek Industries Inc$3.01($.02)(.66%)

  Quote | Ranking | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

 Flotek Industries, Inc. Announces First Quarter 2017 Results And Conference Call Information
   Wednesday, May 03, 2017 4:47:00 PM ET

Flotek Industries, Inc. ("Flotek" or the "Company") (FTK ) today announced results for the three-months ended March 31, 2017.

Q1 2017 Highlights:

-- First quarter revenue from continuing operations was $80.0 million, up 13.2% sequentially, and up 25.3% year-over-year.

-- GAAP loss from continuing operations for the three months ended March 31, 2017, was ($0.7 million), compared with a loss from continuing operations of less than ($0.1 million) in the same period of 2016.

-- Earnings Before Interest, Taxes, Depreciation and Amortization, or EBITDA, was $2.6 million for the three months ended March 31, 2017, compared to $2.6 million for the three months ended March 31, 2016. For comparable purposes to estimates, non-recurring charges of $1.1 million related to executive retirement may be considered, resulting in $3.7 million of adjusted EBITDA. We identified that we recorded $3.0 million associated with non-cash compensation which we intend to identify as non-cash adjustments to EBITDA going forward.

-- Domestic Complex nano-Fluid? (CnF?) volumes rose 24.7% and revenues were up 19.8% sequentially from the 4th quarter 2016. These volumes compare favorably to the U.S. Energy Information Administration Drilling Productivity Report which indicates U.S. land completions rose 22.8% from 4Q16 to 1Q17.

-- International CnF volumes rose 12.1% and revenues were up 4.2% sequentially from the 4th quarter 2016, comparing favorably to broader declines in sequential spending levels.

-- Expected capital expenditures for 2017 are reduced from a previous range of $15 million - $20 million as disclosed in our form 10K to a range of $10 million - $14 million, depending on market conditions, of which, approximately 40% are attributed to growth oriented projects.

Material Subsequent Events Following Q1 Close:

-- On May 2, 2017, Flotek announced the divestiture of its Drilling Technologies segment for proceeds of $17 million, subject to normal working capital adjustments.

-- Ongoing strategic alternatives remain as substantial progress is being made towards the divestiture of our Production Technologies segment, which remains held for sale.

-- On April 25, 2017, Flotek announced a global agreement with IBM to jointly develop greater capabilities to predict and apply custom chemistry and other approaches to enhance the performance of wells throughout their entire life-cycle, highlighting our commitment to lead the effort of Big Data in the Oilfield and jointly create value for our customers.

Segment Results from Continuing Operations:

-- Flotek reported positive results from Energy Chemistry Technologies (ECT), which includes our patented suite of CnF products, but faced challenges with competitive prices in the commodity chemicals offerings.

-- Sequentially, ECT quarterly revenues increased 10.2% to $60.8 million, and year-over-year revenues for the first quarter increased 36.0% due to increased well completion activity by customers and demand for our products.

-- ECT margins in the first quarter rose by 50 basis points from the fourth quarter to 36.7%, and we expect these margins to expand through the course of the year, as price increases implemented in March, combined with process improvements, become more reflected in our results.

-- After a resilient 4th quarter which reflected 23.0% revenue growth from the 3rd quarter, the non-CnF, ECT sales revenue declined 6.1% from the 4th quarter due to timing of customer orders and key customer equipment mobilizations.

-- Consumer & Industrial Chemistry Technologies (CICT) reported revenue of $19.2 million, up 24.1% sequentially, and up 0.3% year-over-year.

-- CICT’s positive growth is, in large part, attributed to flavor and fragrance sales and highlights our focus on managing the supply chain.

John Chisholm, Flotek’s Chairman, President and Chief Executive Officer commented, "As anticipated, overall industry completion activity continued to improve during the quarter, and Flotek is executing on strategic initiatives and organic growth opportunities. We continue to experience increasing demand, above the industry recovery, for our patented CnF? technology.

"Just over a year ago, the price of oil was near its recent low point and we embarked on Company-wide initiatives to position Flotek as a high-return, asset light, technology-focused Company. We maintained our investments in research while the industry cut back, began a strategic review of our operating segments, and developed big data relationships like the recently announced IBM Watson agreement for the benefit of our shareholders and customers.

"We are excited to emerge from the industry downturn in a stronger position in our core operations, technology and relationships with an improved balance sheet and an expanding platform of growth opportunities."

First Quarter 2017 Results For the three months ended March 31, 2017, Flotek posted revenue of $80.0 million, an increase of $16.1 million, or 25.3%, compared to $63.8 million in the same period of 2016. Revenue increased $9.3 million, or 13.2%, compared to the fourth quarter of 2016.

Flotek reported Loss from Operations for the three months ended March 31, 2017 of $0.6 million, an increase of $1.0 million compared to Income from Operations of $0.4 million in the same period of 2016. Loss from Operations decreased $5.0 million compared to fourth quarter 2016.

On a GAAP basis, Flotek reported loss per share (fully diluted) for the three months ended March 31, 2017 of ($0.01) from continuing operations compared to earnings per share (fully diluted) of $0.00 for the three months ended March 31, 2016.

Earnings Before Interest, Taxes, Depreciation and Amortization, or EBITDA, for the three months ended March 31, 2017, was $2.6 million, compared to $2.6 million for the three months ended March 31, 2016.

Consolidated gross margin for the three months ended March 31, 2017, was 34.7% compared to 37.3% in the same period of 2016 and relatively flat with the fourth quarter 2016 margin of 34.5%.

A summary income statement reflecting first quarter results can be found at the conclusion of this release.

First Quarter 2017 - Segment Highlights

                 1Q 2017       4Q 2016       % Change    1Q 2016       % Change
                 Energy Chemistry Technology
Revenue          $60.8 million $55.1 million 10.2%       $44.7 million 36.0%
Gross Margin     36.7%         36.2%                     42.0%
Operating Income $8.5 million  $7.2 million  18.4%       $8.0 million  6.7%
                 Consumer and Industrial Chemistry Technologies ("CICT")
Revenue          $19.2 million $15.5 million 24.1%       $19.1 million 0.3%
Gross Margin     28.3%         18.3%                     26.3%
Operating Income $3.7 million  $1.2 million  220.5%      $3.4 million  9.3%
* Percentage change may be different when calculated due to rounding.

Flotek Outlook In commenting about Flotek’s outlook, Mr. Chisholm added, "For the second quarter 2017, we are anticipating steady completion activity with opportunities for growth, continued demand in energy chemistry with expanding margins as the result of strategic price increases, and steady growth in our consumer and industrial chemistry technology sectors."

Conference Call Details Flotek will host a conference call on Thursday, May 4, at 7:30 AM CDT (8:30 AM EDT) to discuss its operating results for the three months ended March 31, 2017. To participate in the call, participants should dial 800-672-8961 approximately 5 minutes prior to the start of the call. The call can also be accessed from Flotek’s website at

About Flotek Industries, Inc. Flotek develops and delivers prescriptive chemistry-based technology, including specialty chemicals, to clients in the energy, consumer industrials and food & beverage industries. Flotek’s inspired chemists draw from the power of bio-derived solvents to deliver solutions that enhance energy production, cleaning products, foods & beverages and fragrances. In the oil and gas sector, Flotek serves major and independent energy producers and oilfield service companies, both domestic and international. Flotek Industries, Inc. is a publicly traded company headquartered in Houston, Texas, and its common shares are traded on the New York Stock Exchange under the ticker symbol "FTK." For additional information, please visit Flotek’s web site at

Forward-Looking Statements Certain statements set forth in this Press Release constitute forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934) regarding Flotek Industries, Inc.’s business, financial condition, results of operations and prospects. Words such as expects, anticipates, intends, plans, believes, seeks, estimates and similar expressions or variations of such words are intended to identify forward-looking statements, but are not the exclusive means of identifying forward-looking statements in this Press Release.

Although forward-looking statements in this Press Release reflect the good faith judgment of management, such statements can only be based on facts and factors currently known to management. Consequently, forward-looking statements are inherently subject to risks and uncertainties, and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. Factors that could cause or contribute to such differences in results and outcomes include, but are not limited to, demand for oil and natural gas drilling services in the areas and markets in which the Company operates, competition, obsolescence of products and services, the Company’s ability to obtain financing to support its operations, environmental and other casualty risks, and the impact of government regulation.

Further information about the risks and uncertainties that may impact the Company are set forth in the Company’s most recent filings on Form 10-K (including without limitation in the "Risk Factors" Section), and in the Company’s other SEC filings and publicly available documents. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this Press Release. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this Press Release.

Flotek Industries, Inc.
Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings
(in thousands, except per share data)
                                                                  Three Months Ended
                                                                  3/31/2017      3/31/2016
GAAP Net Loss and Reconciliation to EBITDA (Non-GAAP)
Net Loss (GAAP)                                                   $       (743)  $         (29)
                           Interest Expense                       594            408
                           Income Tax Benefit                     (320)          (17)
                           Depreciation and Amortization          3,032          2,250
EBITDA (Non-GAAP)                                                 $      2,563   $      2,612
Select Non-Cash Items Impacting Earnings
Stock Compensation Expense                                        $      3,011   $      2,058
                           Less income tax effect at 35%          (1,054)        (720)
                           Stock Compensation Expense, net of tax $      1,957   $      1,338
Weighted Average Shares Outstanding (Fully Diluted)               57,673         54,744
Stock Compensation Expense Per Share (Fully Diluted)              $        0.03  $        0.02
Flotek Industries, Inc.
Unaudited Condensed Consolidated Balance Sheets
(in thousands, except share data)
                                                                                                                                                                                                                             March 31, 2017         December 31, 2016
Current assets:
Cash and cash equivalents                                                                                                                                                                                                    $               1,826  $                     4,823
Accounts receivable, net of allowance for doubtful accounts of $779 and $664 at March 31, 2017 and December 31, 2016, respectively                                                                                           62,934                 47,152
Inventories                                                                                                                                                                                                                  64,677                 58,283
Income taxes receivable                                                                                                                                                                                                      12,271                 12,752
Assets held for sale                                                                                                                                                                                                         27,891                 43,900
Other current assets                                                                                                                                                                                                         6,694                  21,708
Total current assets                                                                                                                                                                                                         176,293                188,618
Property and equipment, net                                                                                                                                                                                                  74,327                 74,691
Goodwill                                                                                                                                                                                                                     56,660                 56,660
Deferred tax assets, net                                                                                                                                                                                                     20,044                 12,894
Other intangible assets, net                                                                                                                                                                                                 49,726                 50,352
TOTAL ASSETS                                                                                                                                                                                                                 $          377,050     $                383,215
Current liabilities:
Accounts payable                                                                                                                                                                                                             $            35,635    $                   29,960
Accrued liabilities                                                                                                                                                                                                          7,841                  12,170
Interest payable                                                                                                                                                                                                             49                     24
Liabilities held for sale                                                                                                                                                                                                    4,638                  4,961
Current portion of long-term debt                                                                                                                                                                                            42,603                 40,566
Total current liabilities                                                                                                                                                                                                    90,766                 87,681
Long-term debt, less current portion                                                                                                                                                                                         7,083                  7,833
Total liabilities                                                                                                                                                                                                            97,849                 95,514
Commitments and contingencies
Cumulative convertible preferred stock, $0.0001 par value, 100,000 shares authorized; no shares issued and outstanding                                                                                                       --                     --
Common stock, $0.0001 par value, 80,000,000 shares authorized; 59,770,452 shares issued and 57,035,414 shares outstanding at March 31, 2017; 59,684,669 shares issued and 56,972,580 shares outstanding at December 31, 2016 6                      6
Additional paid-in capital                                                                                                                                                                                                   321,980                318,392
Accumulated other comprehensive income (loss)                                                                                                                                                                                (964)                  (956)
Retained earnings (accumulated deficit)                                                                                                                                                                                      (21,808)               (9,830)
Treasury stock, at cost; 2,046,168 and 2,028,847 shares at March 31, 2017 and December 31, 2016, respectively                                                                                                                (20,371)               (20,269)
Flotek Industries, Inc. stockholders’ equity                                                                                                                                                                                 278,843                287,343
Noncontrolling interests                                                                                                                                                                                                     358                    358
Total equity                                                                                                                                                                                                                 279,201                287,701
TOTAL LIABILITIES AND EQUITY                                                                                                                                                                                                 $          377,050     $                383,215
Flotek Industries, Inc.
Unaudited Condensed Consolidated Statements of Operations
(in thousands, except per share data)
                                                                                          Three Months Ended
                                                                                          3/31/2017       3/31/2016
Revenue                                                                                   $   79,954      $   63,812
Cost of revenue                                                                           52,212          40,018
Gross profit                                                                              27,742          23,794
Selling, general and administrative                                                       22,581          19,577
Depreciation and amortization                                                             2,445           1,902
Research and development                                                                  3,141           1,947
Loss on disposal of long-lived assets                                                     198             -
Total expenses                                                                            28,365          23,426
(Loss) income from operations                                                             (623)           368
Other  (expense) income:
Interest expense                                                                          (594)           (408)
Other (expense) income, net                                                               154             (6)
Total other expense                                                                       (440)           (414)
Loss before income taxes                                                                  (1,063)         (46)
Income tax benefit                                                                        320             17
Loss from continuing operations                                                           (743)           (29)
Loss from discontinued operations, net of tax                                             (11,235)        (30,156)
Net loss                                                                                  $ (11,978)      $ (30,185)
Basic earnings (loss) per common share:
Continuing operations                                                                     $      (0.01)   $             -
Discontinued operations, net of tax                                                       (0.19)          (0.55)
Basic earnings (loss) per common share                                                    $      (0.20)   $      (0.55)
Diluted earnings (loss) per common share:
Continuing operations                                                                     $      (0.01)   $             -
Discontinued operations, net of tax                                                       (0.19)          (0.55)
Diluted earnings (loss) per common share                                                  $      (0.20)   $      (0.55)
Weighted average common shares:
Weighted average common shares used in computing basic earnings (loss) per common share   57,673          54,744
Weighted average common shares used in computing diluted earnings (loss) per common share 57,673          54,744
Flotek Industries, Inc.
Unaudited Condensed Consolidated Statements of Cash Flows
(in thousands)
                                                                                                   Three Months Ended
                                                                                                   3/31/2017       3/31/2016
Cash flows from operating activities:
Net loss                                                                                           $ (11,978)      $ (30,185)
Loss from discontinued operations, net of tax                                                      (11,235)        (30,156)
Loss from continuing operations                                                                    (743)           (29)
Adjustments to reconcile loss from continuing operations to net cash used in operating activities:
Depreciation and amortization                                                                      3,032           2,250
Amortization of deferred financing costs                                                           130             87
Loss on sale of assets                                                                             198             0
Stock compensation expense                                                                         3011            2058
Deferred income tax benefit                                                                        (7,403)         (6,898)
Reduction in tax benefit related to share-based awards                                             66              365
Changes in current assets and liabilities:
Accounts receivable                                                                                (15,788)        252
Inventories                                                                                        (6,373)         (10,479)
Income taxes receivable                                                                            332             (10,308)
Other current assets                                                                               13,923          31
Accounts payable                                                                                   5,671           5,801
Accrued liabilities                                                                                1,265           12,274
Income taxes payable                                                                               97              (1,817)
Interest payable                                                                                   25              30
Net cash used in operating activities                                                              (2,557)         (6,383)
Cash flows from investing activities:
Capital expenditures                                                                               (1,877)         (3,790)
Proceeds from sale of assets                                                                       158             -
Purchase of patents and other intangible assets                                                    (84)            (131)
Net cash used in investing activities                                                              (1,803)         (3,921)
Cash flows from financing activities:
Repayments of indebtedness                                                                         (750)           (1,785)
Borrowings on revolving credit facility                                                            98,863          96,000
Repayments on revolving credit facility                                                            (96,826)        (83,526)
Debt issuance costs                                                                                (106)           -
Reduction in tax benefit related to share-based awards                                             -               (365)
Purchase of treasury stock related to share-based awards                                           (102)           (154)
Proceeds from sale of common stock                                                                 251             212
Proceeds from exercise of stock options                                                            7               134
Net cash provided by financing activities                                                          1,337           10,516
Discontinued operations:
Net cash used in operating activities                                                              (353)           (169)
Net cash provided by investing activities                                                          353             169
Net cash flows used in discontinued operations                                                     -               -
Effect of changes in exchange rates on cash and cash equivalents                                   26              60
Net (decrease) increase in cash and cash equivalents                                               (2,997)         272
Cash and cash equivalents at the beginning of period                                               4,823           2,208
Cash and cash equivalents at the end of period                                                     $      1,826    $      2,480

To view the original version on PR Newswire, visit:

SOURCE Flotek Industries, Inc.

Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results, the logo, and News Selects are trademarks of
Copyright © 1998 - 2018 All rights reserved.